Shattuck Labs Inc (STTK)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $473.57M
Last updated: Nov 17, 2026 at 11:05 AM ET
Shattuck Labs Inc (STTK) Competitors
The companies most similar to Shattuck Labs are Tectonic Therapeutic (TECX), SAB Biotherapeutics (SABS) and Syndax Pharmaceuticals (SNDX). By market cap, Shattuck Labs ranks 5th of the 13 companies on this page; Syndax Pharmaceuticals (SNDX) is the largest at $850.77M.
Peer Comparison
STTK's revenue growth of -66.6% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Shattuck Labs (STTK) | $473.57M | N/A | N/A | 0.0% | N/A | -66.6% | 0.00% |
| Tectonic Therapeutic, Inc. (TECX) | $413.27M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| SAB Biotherapeutics Inc (SABS) | $266.66M | N/A | N/A | 0.0% | N/A | -62.4% | 0.00% |
| Syndax Pharmaceuticals Inc (SNDX) | $850.77M | N/A | 2.8x | -72.3% | -65.0% | 81.6% | 0.00% |
| DiaMedica Therapeutics Inc (DMAC) | $474.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Galectin Therapeutics Inc (GALT) | $307.59M | N/A | N/A | 0.0% | 671.1% | 0.0% | 0.00% |
| X4 Pharmaceuticals Inc (XFOR) | $318.59M | N/A | 21.7x | 0.0% | -36.9% | 63.1% | 0.00% |
| CytomX Therapeutics Inc (CTMX) | $444.73M | N/A | 31.0x | 0.0% | -32.8% | -71.7% | 0.00% |
| Puma Biotechnology Inc (PBYI) | $401.70M | 15.0x | 1.6x | 10.3% | N/A | 1.1% | 0.00% |
| Indaptus Therapeutics Inc (INDP) | $422.38M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Immix Biopharma Inc (IMMX) | $657.09M | N/A | N/A | 0.0% | -14.9% | 0.0% | 0.00% |
| Avalo Therapeutics Inc (AVTX) | $448.71M | N/A | N/A | 0.0% | N/A | -69.3% | 0.00% |
| Climb Bio Inc (CLYM) | $608.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $433.55M | 15.0x | 12.2x | 0.0% | -32.8% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Shattuck Labs, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Tectonic Therapeutic, Inc. (TECX) | Tectonic Therapeutic, Inc. engages in the discovery of antibodies and other biologic drugs targeting G-protein-coupled receptors (GPCRs) to develop novel... | TECX competitors |
| SAB Biotherapeutics Inc (SABS) | SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. | SABS competitors |
| Syndax Pharmaceuticals Inc (SNDX) | Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. | SNDX competitors |
| DiaMedica Therapeutics Inc (DMAC) | DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company, develops treatments for neurological and kidney diseases. | DMAC competitors |
| Galectin Therapeutics Inc (GALT) | Galectin Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the research and development of therapies for fibrotic... | GALT competitors |
| X4 Pharmaceuticals Inc (XFOR) | X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development... | XFOR competitors |
| CytomX Therapeutics Inc (CTMX) | CytomX Therapeutics, Inc. is an oncology-focused biopharmaceutical company in the United States. | CTMX competitors |
| Puma Biotechnology Inc (PBYI) | Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States... | PBYI competitors |
| Indaptus Therapeutics Inc (INDP) | Indaptus Therapeutics Inc. is a pioneering biotechnology firm focused on advancing immunotherapies that aim to transform cancer treatment paradigms. | INDP competitors |
| Immix Biopharma Inc (IMMX) | Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology... | IMMX competitors |
| Avalo Therapeutics Inc (AVTX) | Avalo Therapeutics Inc is a forward-thinking clinical-stage biotechnology company focused on developing transformative therapies for rare and underserved... | AVTX competitors |
| Climb Bio Inc (CLYM) | Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. | CLYM competitors |
Frequently Asked Questions About STTK
Who are Shattuck Labs' main competitors?
The companies most similar to Shattuck Labs include Tectonic Therapeutic (TECX), SAB Biotherapeutics (SABS), Syndax Pharmaceuticals (SNDX), DiaMedica Therapeutics (DMAC) and Galectin Therapeutics (GALT), listed from the closest match.
Who is Shattuck Labs' biggest competitor?
Syndax Pharmaceuticals (SNDX) is the largest of the similar companies at $850.77M; Tectonic Therapeutic (TECX) is the closest match by business profile, size, sector and industry.
How does STTK stock compare with its competitors?
STTK's net margin is 0.0% against a peer median of 0.0%.
Which of Shattuck Labs' competitors pays a higher dividend?
Shattuck Labs pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Shattuck Labs bigger than its competitors?
No. Shattuck Labs is 5th by market cap among the 13 companies on this page; the largest is Syndax Pharmaceuticals (SNDX) at $850.77M.
STTK pages: Overview, Earnings, Forecast, Financials, Competitors